Neurocrine Biosciences
NBIX
#1482
Rank
ยฃ9.10 B
Marketcap
ยฃ90.18
Share price
-1.75%
Change (1 day)
-3.01%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of June 2024 : ยฃ0.79 B

According to Neurocrine Biosciences 's latest financial reports the company has ยฃ0.79 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ0.80 B-0.98%
2022-12-31ยฃ0.81 B55.59%
2021-12-31ยฃ0.52 B-10.43%
2020-12-31ยฃ0.58 B16.13%
2019-12-31ยฃ0.50 B-0.96%
2018-12-31ยฃ0.51 B33.64%
2017-12-31ยฃ0.38 B53.26%
2016-12-31ยฃ0.24 B-2.55%
2015-12-31ยฃ0.25 B105.31%
2014-12-31ยฃ0.12 B41.08%
2013-12-31ยฃ88.24 M-17.52%
2012-12-31ยฃ0.10 B28.81%
2011-12-31ยฃ83.06 M0.73%
2010-12-31ยฃ82.45 M147.58%
2009-12-31ยฃ33.3 M-40.32%
2008-12-31ยฃ55.81 M-37.88%
2007-12-31ยฃ89.84 M-3.63%
2006-12-31ยฃ93.22 M-41.13%
2005-12-31ยฃ0.15 B0.86%
2004-12-31ยฃ0.15 B-38.56%
2003-12-31ยฃ0.25 B67.43%
2002-12-31ยฃ0.15 B-30.85%
2001-12-31ยฃ0.22 B100.03%
2000-12-31ยฃ0.11 B95.69%
1999-12-31ยฃ56.38 M701.28%
1998-12-31ยฃ7.03 M-26.84%
1997-12-31ยฃ9.61 M45.75%
1996-12-31ยฃ6.59 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.61 B-22.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.94 B 145.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ7.63 M-99.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.56 B 223.80%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.02 B 1,166.44%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.41 B 583.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.18 B-76.22%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.77 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA